Revenue Estimates Analysis of Assertio Therapeutics, Inc.(NASDAQ:ASRT): Adtalem Global Education Inc.(NYSE:ATGE)

0
3

Assertio Therapeutics, Inc. (ASRT) will report its next earnings on Aug 07 AMC. The company reported the earnings of $0.25/Share in the last quarter where the estimated EPS by analysts was $0.24/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 4.2%.

Many analysts are providing their Estimated Earnings analysis for Assertio Therapeutics, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.25/share. These analysts have also projected a Low Estimate of $0.21/share and a High Estimate of $0.28/share.

These analysts also forecasted Growth Estimates for the Current Quarter for ASRT to be -45.2%. They are projecting Next Quarter growth of -36.67%. For the next 5 years, Assertio Therapeutics, Inc. is expecting Growth of 0.56% per annum, whereas in the past 5 years the growth was -27.05% per annum.

Some buy side analysts are also providing their Analysis on Assertio Therapeutics, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Assertio Therapeutics, Inc. might touch $9.5 high while the Average Price Target and Low price Target is $4.88 and $3 respectively.

Assertio Therapeutics, Inc. closed its last trading session at $1.52 with the gain of 0%. The Market Capitalization of the company stands at 181 Million. The Company has 52-week high of $8.08 and 52-week low of $1.49. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -49.38% where SMA50 and SMA200 are -51.14% and -63.2% respectively. The Company Touched its 52-Week High on 08/15/18 and 52-Week Low on 08/09/19.

The Relative Volume of the company is 2.59 and Average Volume (3 months) is 843.2 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 1.62.

The company shows its Return on Assets (ROA) value of -1.2%. The Return on Equity (ROE) value stands at -5.2%. While it’s Return on Investment (ROI) value is 13.3%.

While looking at the Stock’s Performance, Assertio Therapeutics, Inc. currently shows a Weekly Performance of -46.67%, where Monthly Performance is -51.28%, Quarterly performance is -64.49%, 6 Months performance is -64.57% and yearly performance percentage is -79.88%. Year to Date performance value (YTD perf) value is -57.89%. The Stock currently has a Weekly Volatility of 25.81% and Monthly Volatility of 11.67%.

Adtalem Global Education Inc. (ATGE) will report its next earnings on Aug 22 AMC. The company reported the earnings of $0.68/Share in the last quarter where the estimated EPS by analysts was $0.65/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 4.6%.

Many analysts are providing their Estimated Earnings analysis for Adtalem Global Education Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.96/share. These analysts have also projected a Low Estimate of $0.95/share and a High Estimate of $0.97/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Adtalem Global Education Inc. as 328.63 Million. According to these analysts, the Low Revenue Estimate for Adtalem Global Education Inc. is 324.8 Million and the High Revenue Estimate is 331 Million. The company had Year Ago Sales of 319.79 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ATGE to be 11.6%. They are projecting Next Quarter growth of 20%. For the next 5 years, Adtalem Global Education Inc. is expecting Growth of 9.54% per annum, whereas in the past 5 years the growth was 1.8% per annum.

Some buy side analysts are also providing their Analysis on Adtalem Global Education Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Adtalem Global Education Inc. might touch $55 high while the Average Price Target and Low price Target is $50.25 and $47 respectively.

Adtalem Global Education Inc. closed its last trading session at $48.09 with the loss of -0.77%. The Market Capitalization of the company stands at 2.71 Billion. The Company has 52-week high of $58.80 and 52-week low of $42.36. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.87% where SMA50 and SMA200 are 4.01% and -1.1% respectively. The Company Touched its 52-Week High on 11/13/18 and 52-Week Low on 05/20/19.

The Relative Volume of the company is 0.57 and Average Volume (3 months) is 324.35 million. The company’s P/E (price to earnings) ratio is 21.85 and Forward P/E ratio of 15.39.

The company shows its Return on Assets (ROA) value of 4.8%. The Return on Equity (ROE) value stands at 7.5%. While it’s Return on Investment (ROI) value is 9.4%.

While looking at the Stock’s Performance, Adtalem Global Education Inc. currently shows a Weekly Performance of 7.43%, where Monthly Performance is 4.12%, Quarterly performance is 8.36%, 6 Months performance is -0.1% and yearly performance percentage is -13.63%. Year to Date performance value (YTD perf) value is 0.85%. The Stock currently has a Weekly Volatility of 2.75% and Monthly Volatility of 2.38%.

SHARE